An Approved Vendor for
Over 14 Years

>750 Studies Supported

>275 Scientists
Supported

BMS has dedicated support from Strategic Account Management focused on orchestrating true enterprise-wide partnership between our organizations. Our aim is to streamline communications, strengthen relationships, facilitate agreements, broaden support, and expedite solutions to advance BMS projects.

Over the years, Discovery has delivered creative solutions across multiple BMS research groups. Examples of these tailored services and biospecimens solutions include high-throughput RNA, whole genome, exome, targeted sequencing, customizable multiplex immunoassays, and custom biospecimen bank builds.

Tumor NGS

Fresh tumor collection with custom dissociation protocol that was then used for CITEseq and bulk exome seq pilot. 

Biobank Build

Custom immunology biobank build including storage services; 10,000 biospecimens currently housed at Discovery.

Compound Testing

BMS compound testing;  Discovery collected blood samples and performed custom cell  culture, flow cytometry, and  RNA sequencing. 

• Largest selection available spanning most solid tumor indications
• World-class scientific support for DTCs utilization
• Flow and genomic characterizations available for optimal sample selections

• Pathologist reviewed FFPE blocks and matched sets

• 40x Digital H&E images of all blocks for easy review and selection 

• Wide range of expert tissue biomarker and genomic services available

• GMP and RUO Leukopaks
• 99% delivery rate
• Tens of thousands of highly characterized donors available
• World's largest apheresis capacity to deliver RUO and GMP-compliant products

Reliable and customizable proteomic services from mass spectrometry to multiplexed immunoassays enabling improved understanding of real-time human biology.

High-throughput RNA-Seq, WES, targeted and pan-caner sequencing workflows optimized in GCLP-compliant service laboratories for the most challenging sample types such as FFPE and core needle biopsies. 

Pathologist-driven, GCLP compliant procedures for developing and validating custom mIF assays in CAP-accredited and CLIA-certified service laboratories.